WallStreetZenWallStreetZen

NYSEMKT: IGC
Igc Pharma Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Igc Pharma revenue was $1.33M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q2 2025) ending on Jun 30, 2025 was $328.0k, down 0.6% from last quarter. For the last reported fiscal year 2025 ending Mar 31, 2025, IGC annual revenue was $1.3M, with -5.5% growth year-over-year.

IGC past revenue growth

How has IGC's revenue growth performed historically?

Company
24.95%
Industry
146.83%
Market
17.01%
IGC's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
IGC's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
IGC's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

IGC revenue history

Current Revenue
$1.3M
Current Earnings
-$6.3M
Current Profit Margin
-477.9%

Be the first to know when IGC announces revenue.

IGC Revenue History By Year

IGC Yearly RevenueIGC RevenueIGC ChangeIGC Revenue Growth
2025-03-31$1.27M-$74.00k-5.50%
2024-03-31$1.35M$434.00k+47.64%
2023-03-31$911.00k$514.00k+129.47%
2022-03-31$397.00k-$501.00k-55.79%
2021-03-31$898.00k-$3.17M-77.95%
2020-03-31$4.07M-$1.04M-20.41%
2019-03-31$5.12M$2.92M+133.29%
2018-03-31$2.19M$1.61M+277.86%
2017-03-31$580.37k-$5.79M-90.88%
2016-03-31$6.37M-$1.31M-17.10%
2015-03-31$7.68M$5.41M+237.87%
2014-03-31$2.27M-$5.76M-71.69%
2013-03-31$8.03M$3.83M+91.21%
2012-03-31$4.20M$125.63k+3.08%
2011-03-31$4.07M-$13.82M-77.24%
2010-03-31$17.90M-$17.44M-49.35%
2009-03-31$35.34M$33.15M+1,515.10%
2008-03-31$2.19MN/AN/A
2007-03-31$0.00N/AN/A
2006-03-31$0.00N/AN/A

1 of 2

Igc Pharma Revenue FAQ

What was IGC's revenue last quarter?

On Invalid Date, Igc Pharma (NYSEMKT: IGC) reported Q2 2025 revenue of $328.00 thousand up 20.59% year over year. In the same quarter last year, Igc Pharma's revenue was $272.00 thousand.

What was Igc Pharma's revenue in 2025?

Igc Pharma's annual revenue for the twelve months ending Mar 31, 2025 was $1.27 million, a 5.5% decrease year over year.

How much does Igc Pharma make in a day?

Based on Igc Pharma annual revenue for the past five years, IGC makes an average of $2,642.19 per day.

What was Igc Pharma's annual revenue growth in the past year?

As of Q3 2025, Igc Pharma's revenue has grown 24.95% year over year. This is 121.88 percentage points lower than the US Biotechnology industry revenue growth rate of 146.83%. Igc Pharma's revenue in the past year totaled $1.33 million.

How much does Igc Pharma make in a year?

Igc Pharma's revenue by year for the past five years is:
  • Igc Pharma's revenue for the twelve months ending Mar 31, 2025 was $1.27 million, a 5.5% decrease year over year.
  • Igc Pharma's annual revenue for Mar 31, 2024 was $1.35 million, a 47.64% increase from 2023.
  • Igc Pharma's annual revenue for 2023 was $911.00 thousand, a 129.47% increase from 2022.
  • Igc Pharma's annual revenue for 2022 was $397.00 thousand, a 55.79% decrease from 2021.
  • Igc Pharma's annual revenue for 2021 was $898.00 thousand, a 77.95% decrease from 2020.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.